Australia: Amgen Receives Patent for 'KRAS G12C inhibitors encompassing a piperazine ring and use thereof in the treatment of cancer'

  • Thomas Nguyen

Press/Media

Period29 Jul 2022

Media coverage

1

Media coverage

  • TitleAustralia: Amgen Receives Patent for 'KRAS G12C inhibitors encompassing a piperazine ring and use thereof in the treatment of cancer'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date29/07/22
    PersonsThomas Nguyen
View all 1
View less